Exozymes Inc. (EXOZ) stock
Close on Nov 13, 2026Market cap $35.55MP/E –Yield –
Exozymes statistics
62 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 16.22
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 6.66%
- 10.8%
- Shares Change (QoQ)
- 0.25%
- 0.50%
- Float
- 3M
- 49M
- Shares Held by Insiders
- 71.3%
- 11.7%
- Shares Held by Institutions
- 1.34%
- 56.4%
Short sellingIndustry
- Short Interest
- 17,877
- –
- Short Interest Change
- 1.26%
- -0.80%
- Short % of Float
- 0.67%
- 9.01%
- Short % of Shares Outstanding
- 0.19%
- 6.30%
- Days to Cover
- 1.17
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $16.90
- –
- 52-Week Low
- $3.24
- –
- 20-Day Moving Average
- $4.11
- –
- 50-Day Moving Average
- $5.12
- –
- 200-Day Moving Average
- $7.42
- –
- Average True Range (14)
- $0.52
- –
- Price Change (1 Week)
- -13.0%
- -1.15%
- Price Change (1 Month)
- -4.25%
- -4.87%
- Price Change (3 Months)
- -36.5%
- -21.0%
- Price Change (6 Months)
- -60.8%
- -20.6%
- Price Change (YTD)
- -64.9%
- -23.6%
- Price Change (1 Year)
- -76.8%
- -22.4%
- Average Volume (10 Days)
- 12,082
- –
- Average Volume (20 Days)
- 13,003
- –
- Average Volume (90 Days)
- 8,922
- –
- Relative Volume
- 2.27
- 0.70
- Relative Strength Index (14)
- 37.0
- 43.4
- Volatility (1 Year)
- 77.6%
- 80.1%
- Beta (5 Years)
- 1.19
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -268.1%
- -49.9%
- Return on Assets (ROA)
- -149.4%
- -40.6%
- Return on Capital Employed (ROCE)
- -266.0%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.30
- 3.30
- Quick Ratio
- 1.92
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$316.95K
- -$689.41K
- Employee Count
- 32
- 74
- WACC
- 11.1%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$10.25M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $3.26M
- $17.76M
- Net Cash Per Share
- $0.35
- $0.80
- Equity (Book Value)
- $2.19M
- $53.89M
- Book Value Per Share
- $0.24
- $1.50
- Tangible Book Value
- $2.19M
- $27.13M
- Working Capital
- $2.21M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$442.57K
- -$1.00M
- FCF Per Share
- -$0.84
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -28.5%
- -21.8%
- FCF Yield
- -21.9%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- -6.80
- 0.23
- Piotroski F-Score
- 1
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | EXOZ | S&P 500 | Difference | EXOZ per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -16.6% | -3.0% | −13.5 pts | ||
| 3 months | -36.2% | -2.8% | −33.4 pts | ||
| Year to date | -64.9% | +11.5% | −76.4 pts | ||
| 1 year | -76.6% | +13.5% | −90.1 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M EXOZ shares were sold short on Oct 30, 2026, up 1.3% from the previous report, or 0.67% of the shares available to trade. At recent volumes it would take 1.2 days to buy them back. Over the last 20 sessions, 21.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 17,877 | +1.3% | 15,318 | 1.2 |
| Oct 15, 2026 | 17,654 | -4.4% | 9,163 | 1.9 |
| Sep 30, 2026 | 18,469 | -9.5% | 8,995 | 2.0 |
| Sep 15, 2026 | 20,419 | -6.4% | 6,641 | 3.1 |
| Aug 31, 2026 | 21,807 | +11.7% | 4,575 | 4.8 |
| Aug 14, 2026 | 19,516 | -10.9% | 5,311 | 3.7 |
| Jul 31, 2026 | 21,892 | +11.8% | 8,340 | 2.6 |
| Jul 15, 2026 | 19,579 | +24.5% | 19,312 | 1.0 |
| Jun 30, 2026 | 15,720 | +6.3% | 10,596 | 1.5 |
| Jun 15, 2026 | 14,786 | -1.7% | 7,865 | 1.9 |
| May 29, 2026 | 15,037 | +25.5% | 4,759 | 3.2 |
| May 15, 2026 | 11,977 | -4.7% | 2,386 | 5.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?